Marsh & McLennan Companies, Inc.
NYSE:MRSHInsurance - Brokers
-$2.87 today
- Market cap
- $98.03B
- Beta
- 0.61
- P/E (TTM)
- 19.9
- EPS (TTM)
- $8.11
- Dividend yield
- 2.23%
Volume 1.40M
Average 3.00M
MRSH Account Payables
Amounts the company owes suppliers for goods and services received.
Marsh & McLennan Companies, Inc.NYSE: MRSH
Account Payables · Q3 FY2026 · quarter ended Sep 2026
Account payables rises 6.8% from a year ago
Account payables stood at $3.58B at the end of Q3 FY2026, up 6.8% from a year earlier and down 11.6% from the prior quarter. Over 3 fiscal years it compounded at +3.7% a year.
Context
- Account payables amounted to 6.0% of total assets at the end of Q3 FY2026, up 0.3 pp from a year earlier.
- Account payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +6.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 3.65B USD
- Year-over-year change
- +7.3%
- 4-year CAGR
- +3.6%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.65B | +7.3% |
| FY2024 | 2024-12-31 | 3.4B | -0.0% |
| FY2023 | 2023-12-31 | 3.4B | +3.8% |
| FY2022 | 2022-12-31 | 3.28B | +3.6% |
| FY2021 | 2021-12-31 | 3.17B | — |
Account Payables vs competitors
How MRSH compares with its peers on the latest reported figures
- MRSH's Sep 2026 account payables of $3.58B is the highest of the 7 companies compared; the peer median is $211.51M.
- Its year-over-year change of +6.8% is the 2nd highest of 5, against a peer median of -8.9%.
- Account payables amounts to 6.0% of total assets for MRSH, versus a peer median of 1.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $3.58B | +6.8% | +3.7% | 6.0% | |
| Jun 2026 | $2.27B | -1.2% | +10.6% | 4.2% | |
| Sep 2026 | $709M | -16.5% | +51.2% | 2.4% | |
| Jun 2026 | $340.82M | — | — | 2.8% | |
| Sep 2026 | $82.2M | +19.7% | +13.7% | 1.4% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | -100.0% | +0.4% | 0.0% | |
| Peer median (excluding MRSH) | $211.51M | -8.9% | +12.1% | 1.9% | |
Competitors are the stored peer set for MRSH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.75B | 1.44B | 3.36B | 2.4B | 2.69B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 5.59B | 5.85B | 6.42B | 7.16B | 7.67B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 926M | 11.67B | 11.97B | 12.56B | 12.84B |
| Total Current Assets | 8.26B | 18.96B | 21.75B | 22.12B | 23.2B |
| Property, Plant & Equipment (Net) | 2.72B | 2.43B | 2.42B | 2.36B | 2.29B |
| Goodwill | 16.32B | 16.25B | 17.23B | 23.31B | 24.34B |
| Intangible Assets | 2.81B | 3.03B | 2.63B | 4.82B | 5.21B |
| Long-term Investments | 2.27B | 396M | 449M | 541M | 515M |
| Tax Assets | 551M | 0 | 357M | 237M | 0 |
| Other Non-current Assets | 1.46B | 3.05B | 3.19B | 3.1B | 3.16B |
| Total Non-current Assets | 26.12B | 25.16B | 26.28B | 34.36B | 35.51B |
| Total Assets | 34.39B | 44.11B | 48.03B | 56.48B | 58.71B |
| Account Payables | 3.17B | 3.28B | 3.4B | 3.4B | 3.65B |
| Short-term Debt | 17M | 268M | 1.62B | 519M | 1.27B |
| Tax Payables | 198M | 221M | 321M | 376M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.94B | 13.76B | 14.14B | 14.9B | 15.44B |
| Total Current Liabilities | 6.65B | 17.83B | 19.8B | 19.52B | 21.06B |
| Long-term Debt | 10.93B | 11.23B | 11.84B | 19.43B | 18.32B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 3.7B | 2.64B | 2.36B | 2.41B | 2.49B |
| Total Non-current Liabilities | 16.51B | 15.53B | 15.87B | 23.43B | 22.34B |
| Total Liabilities | 23.17B | 33.37B | 35.66B | 42.95B | 43.4B |
| Common Stock | 561M | 561M | 561M | 561M | 561M |
| Retained Earnings | 18.39B | 20.3B | 22.76B | 25.31B | 27.77B |
| Accumulated OCI | (4.58B) | (5.31B) | (5.3B) | (6.24B) | (5.43B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 213M | 229M | 179M | 193M | 215M |
| Total Equity | 11.22B | 10.75B | 12.37B | 13.54B | 15.32B |
| Total Debt | 13.16B | 13.47B | 15.44B | 21.86B | 21.45B |
| Net Debt | 11.41B | 12.03B | 12.08B | 19.46B | 18.76B |
Marsh & McLennan Companies, Inc.
NYSE:MRSH
Intrinsic Alpha fair value
Locked
Current Price
$205.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.